217 related articles for article (PubMed ID: 30213806)
1. CT versus MR Imaging in Estimating Cochlear Radiation Dose during Gamma Knife Surgery for Vestibular Schwannomas.
Faramand AM; Kano H; Johnson S; Niranjan A; Flickinger JC; Lunsford LD
AJNR Am J Neuroradiol; 2018 Oct; 39(10):1907-1911. PubMed ID: 30213806
[TBL] [Abstract][Full Text] [Related]
2. Gamma knife radiosurgery for vestibular schwannoma: early hearing outcomes and evaluation of the cochlear dose.
Lasak JM; Klish D; Kryzer TC; Hearn C; Gorecki JP; Rine GP
Otol Neurotol; 2008 Dec; 29(8):1179-86. PubMed ID: 18931646
[TBL] [Abstract][Full Text] [Related]
3. Gamma knife radiosurgery for vestibular schwannomas: results of hearing preservation in relation to the cochlear radiation dose.
Timmer FC; Hanssens PE; van Haren AE; Mulder JJ; Cremers CW; Beynon AJ; van Overbeeke JJ; Graamans K
Laryngoscope; 2009 Jun; 119(6):1076-81. PubMed ID: 19399836
[TBL] [Abstract][Full Text] [Related]
4. Dosimetric Analysis of Neural and Vascular Structures in Skull Base Tumors Treated with Stereotactic Radiosurgery.
Haidar YM; Bhatt JM; Ghavami Y; Moshtaghi O; Schwer A; Chenery S; Djalilian HR
Otolaryngol Head Neck Surg; 2017 May; 156(5):857-862. PubMed ID: 28195750
[TBL] [Abstract][Full Text] [Related]
5. Radiosurgery of vestibular schwannoma: prognostic factors for hearing outcome using 3D-constructive interference in steady state (3D-CISS).
Wagner F; Gandalini M; Hakim A; Ermis E; Leiser D; Zbinden M; Anschuetz L; Raabe A; Caversaccio M; Wiest R; Herrmann E
Strahlenther Onkol; 2018 Dec; 194(12):1132-1143. PubMed ID: 30203112
[TBL] [Abstract][Full Text] [Related]
6. Inherent functional dependence among cochlear dose surrogates for stereotactic radiosurgery of vestibular schwannomas.
Ma L; Braunstein SE; Theodosopoulos PV; McDermott MW; Sneed PK
Pract Radiat Oncol; 2017; 7(1):e1-e7. PubMed ID: 27742557
[TBL] [Abstract][Full Text] [Related]
7. Stereotactic radiosurgery for vestibular schwannomas: average 10-year follow-up results focusing on long-term hearing preservation.
Watanabe S; Yamamoto M; Kawabe T; Koiso T; Yamamoto T; Matsumura A; Kasuya H
J Neurosurg; 2016 Dec; 125(Suppl 1):64-72. PubMed ID: 27903183
[TBL] [Abstract][Full Text] [Related]
8. Long-term follow-up studies of Gamma Knife surgery for patients with neurofibromatosis Type 2.
Sun S; Liu A
J Neurosurg; 2014 Dec; 121 Suppl():143-9. PubMed ID: 25434947
[TBL] [Abstract][Full Text] [Related]
9. Hearing preservation in patients with vestibular schwannoma treated with Gamma Knife surgery.
Baschnagel AM; Chen PY; Bojrab D; Pieper D; Kartush J; Didyuk O; Naumann IC; Maitz A; Grills IS
J Neurosurg; 2013 Mar; 118(3):571-8. PubMed ID: 23216466
[TBL] [Abstract][Full Text] [Related]
10. Dosimetric comparison of Linac-based (BrainLAB®) and robotic radiosurgery (CyberKnife ®) stereotactic system plans for acoustic schwannoma.
Dutta D; Balaji Subramanian S; Murli V; Sudahar H; Gopalakrishna Kurup PG; Potharaju M
J Neurooncol; 2012 Feb; 106(3):637-42. PubMed ID: 21892741
[TBL] [Abstract][Full Text] [Related]
11. Cochlea radiation dose correlates with hearing loss after stereotactic radiosurgery of vestibular schwannoma.
Hayden Gephart MG; Hansasuta A; Balise RR; Choi C; Sakamoto GT; Venteicher AS; Soltys SG; Gibbs IC; Harsh GR; Adler JR; Chang SD
World Neurosurg; 2013; 80(3-4):359-63. PubMed ID: 22484770
[TBL] [Abstract][Full Text] [Related]
12. Increased cochlear radiation dose predicts delayed hearing loss following both stereotactic radiosurgery and fractionated stereotactic radiotherapy for vestibular schwannoma.
Patel KS; Ng E; Kaur T; Miao T; Kaprealian T; Lee P; Pouratian N; Selch MT; De Salles AAF; Gopen Q; Tenn S; Yang I
J Neurooncol; 2019 Nov; 145(2):329-337. PubMed ID: 31552587
[TBL] [Abstract][Full Text] [Related]
13. Significance of cochlear dose in the radiosurgical treatment of vestibular schwannoma: controversies and unanswered questions.
Jacob JT; Carlson ML; Schiefer TK; Pollock BE; Driscoll CL; Link MJ
Neurosurgery; 2014 May; 74(5):466-74; discussion 474. PubMed ID: 24476904
[TBL] [Abstract][Full Text] [Related]
14. Gamma Knife radiosurgery for intravestibular and intracochlear schwannomas.
Tuleasca C; George M; Schiappacasse L; Patin D; Fenu J; Maire R; Levivier M
Acta Neurochir (Wien); 2019 Jan; 161(1):63-67. PubMed ID: 30535852
[TBL] [Abstract][Full Text] [Related]
15. Factors associated with hearing preservation after Gamma Knife surgery for vestibular schwannomas in patients who retain serviceable hearing.
Hasegawa T; Kida Y; Kato T; Iizuka H; Yamamoto T
J Neurosurg; 2011 Dec; 115(6):1078-86. PubMed ID: 21961962
[TBL] [Abstract][Full Text] [Related]
16. Effect of subpixel magnetic resonance imaging shifts on radiosurgical dosimetry for vestibular schwannoma.
Borden JA; Tsai JS; Mahajan A
J Neurosurg; 2002 Dec; 97(5 Suppl):445-9. PubMed ID: 12507073
[TBL] [Abstract][Full Text] [Related]
17. Irradiation of cochlear structures during vestibular schwannoma radiosurgery and associated hearing outcome.
Massager N; Nissim O; Delbrouck C; Delpierre I; Devriendt D; Desmedt F; Wikler D; Brotchi J; Levivier M
J Neurosurg; 2007 Oct; 107(4):733-9. PubMed ID: 17937216
[TBL] [Abstract][Full Text] [Related]
18. Stereotactic radiosurgery versus stereotactic radiotherapy for patients with vestibular schwannoma: a Leksell Gamma Knife Society 2000 debate.
Linskey ME
J Neurosurg; 2000 Dec; 93 Suppl 3():90-5. PubMed ID: 11143270
[TBL] [Abstract][Full Text] [Related]
19. Predictors of hearing loss after gamma knife radiosurgery for vestibular schwannomas: age, cochlear dose, and tumor coverage.
Brown M; Ruckenstein M; Bigelow D; Judy K; Wilson V; Alonso-Basanta M; Lee JY
Neurosurgery; 2011 Sep; 69(3):605-13; discussion 613-4. PubMed ID: 21471832
[TBL] [Abstract][Full Text] [Related]
20. Hearing preservation following fractionated stereotactic radiotherapy for vestibular schwannomas: prognostic implications of cochlear dose.
Thomas C; Di Maio S; Ma R; Vollans E; Chu C; Clark B; Lee R; McKenzie M; Martin M; Toyota B
J Neurosurg; 2007 Nov; 107(5):917-26. PubMed ID: 17977261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
